ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,459Medicare Part D Prescriptions Filled, Including Refills

Rank: 26 out of 1121

$1.06M Total Retail Price of All Prescriptions

Rank: 58 out of 1121

758 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 758 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 758 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 22,191 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
FUROSEMIDE 848 782 1 7
LEVOTHYROXINE SODIUM 744 705 2 2
SIMVASTATIN 666 571 3 1
METFORMIN HCL 633 555 4 8
OMEPRAZOLE 618 587 5 6
LISINOPRIL 591 507 6 4
METOPROLOL TARTRATE 576 507 7 9
PRAVASTATIN SODIUM 540 488 8 14
HYDROCHLOROTHIAZIDE 419 392 9 10
AMLODIPINE BESYLATE 417 393 10 5
WARFARIN SODIUM 404 347 11 11
GABAPENTIN 402 356 12 13
CITALOPRAM HBR 313 286 13 18
ALLOPURINOL 302 290 14 30
HYDROCODONE-ACETAMINOPHEN 297 282 S3 15 3
SPIRONOLACTONE 286 258 16 54
BISOPROLOL FUMARATE 285 285 17 204
NAMENDA 275 263 18 53
ATENOLOL 256 205 19 16
LOVASTATIN 254 230 20 26
PREDNISONE 250 236 21 43
DIGOXIN 241 225 22 59
ZOLPIDEM TARTRATE 235 203 23 19
ENALAPRIL MALEATE 232 232 24 73
LISINOPRIL-HYDROCHLOROTHIAZIDE 232 226 24 31
CLOPIDOGREL 225 198 26 27
RANITIDINE HCL 224 184 27 33
TAMSULOSIN HCL 213 205 28 32
PANTOPRAZOLE SODIUM 212 211 29 29
SERTRALINE HCL 211 200 30 21
CLONIDINE HCL 203 193 31 39
TRAMADOL HCL 198 165 32 25
GLIPIZIDE 196 192 33 84
ATORVASTATIN CALCIUM 192 176 34 15
METOPROLOL SUCCINATE 191 179 35 23
POTASSIUM CHLORIDE 189 146 36 12
POLYETHYLENE GLYCOL 3350 176 157 37 70
GLIMEPIRIDE 174 169 38 34
TRAZODONE HCL 173 166 39 40
TRIAMTERENE-HCTZ 168 143 40 38
MIRTAZAPINE 163 163 41 56
NEXIUM 162 146 42 24
ISOSORBIDE MONONITRATE ER 156 156 43 62
JANTOVEN 149 149 44 146
PLAVIX 148 130 45 42
CARVEDILOL 147 138 46 20
SPIRONOLACTONE-HCTZ 144 143 47 240
AMITRIPTYLINE HCL 143 103 R 48 61
ZETIA 142 130 49 80
ERYPED 200 140 63 10 50 373
FLUTICASONE PROPIONATE 140 125 50 36
CIPROFLOXACIN HCL 138 130 52 57
LOSARTAN POTASSIUM 137 130 53 17
GLIPIZIDE ER 121 118 54 142
GALANTAMINE HBR 121 121 54 243
FINASTERIDE 121 121 54 117
CRESTOR 107 107 57 28
TRAMADOL HCL-ACETAMINOPHEN 107 104 57 194
FLUOXETINE HCL 101 92 59 60
DONEPEZIL HCL 100 97 60 35
JANUVIA 100 80 60 81
BENAZEPRIL HCL 97 97 62 41
GEMFIBROZIL 96 90 63 88
LANTUS 95 83 64 52
FAMOTIDINE 95 93 64 63
CYMBALTA 92 60 66 50
SPIRIVA 92 90 66 49
DIOVAN 92 65 66 45
KLOR-CON 10 88 88 69 69
GLYBURIDE 87 82 R 70 51
AMOX TR-POTASSIUM CLAVULANATE 87 80 70 101
TRIAMCINOLONE ACETONIDE 84 82 72 169
CARBIDOPA-LEVODOPA 83 83 73 118
SINGULAIR 82 64 74 78
INSULIN SYRINGE 81 42 75 77
FLUCONAZOLE 80 69 76 156
LIPITOR 78 73 77 106
DOXYCYCLINE HYCLATE 75 74 78 103
METHOTREXATE 75 71 78 248
DIOVAN HCT 74 74 80 90
ACETAMINOPHEN-CODEINE 74 68 S3 80 161
RISPERIDONE 74 74 80 82
MELOXICAM 73 69 83 22
NORTRIPTYLINE HCL 73 73 83 215
DILTIAZEM ER 72 70 85 105
OXYBUTYNIN CHLORIDE 71 68 86 128
INDAPAMIDE 70 62 87 138
LANSOPRAZOLE 70 68 87 162
LEVETIRACETAM 69 35 89 125
CEFUROXIME 69 65 89 163
LOSARTAN-HYDROCHLOROTHIAZIDE 67 67 91 46
LABETALOL HCL 67 67 91 164
ALENDRONATE SODIUM 64 64 93 37
FENOFIBRATE 63 50 94 71
ESTRADIOL 62 55 R 95 95
AMIODARONE HCL 62 62 95 188
SULINDAC 62 50 95 339
PAROXETINE HCL 61 56 98 58
PROAIR HFA 61 51 98 48
ESTROPIPATE 60 60 R 100 450
BUSPIRONE HCL 59 57 101 114
BENAZEPRIL-HYDROCHLOROTHIAZIDE 57 57 102 153
BISOPROLOL-HYDROCHLOROTHIAZIDE 57 57 102 179
VENTOLIN HFA 57 56 102 92
THEOPHYLLINE ANHYDROUS 57 55 102 175
NIFEDIPINE ER 57 57 102 102
JANUMET 56 44 107 167
LEXAPRO 55 42 108 218
ENALAPRIL-HYDROCHLOROTHIAZIDE 54 39 109 296
RAMIPRIL 54 54 109 74
SULFAMETHOXAZOLE-TRIMETHOPRIM 53 51 111 108
COLESTIPOL HCL 53 49 111 333
VERAPAMIL ER 53 53 111 89
MECLIZINE HCL 52 52 114 115
SOTALOL 52 52 114 199
HYDRALAZINE HCL 52 52 114 66
PREMARIN 51 40 R 117 96
PHENYTOIN SODIUM EXTENDED 51 41 117 135
NOVOLOG 50 30 119 139
DOXAZOSIN MESYLATE 50 50 119 93
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 11, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.